Administration of Anti–SARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization

This cross-sectional study uses time-series data to evaluate the administration of bamlanivimab-etesevimab and casirivimab-imdevimab monoclonal antibody treatments for SARS-CoV-2 infection after the US Food and Drug Administration deauthorized their use in early 2022.

Detalles Bibliográficos
Autores principales: Anderson, Timothy S., O’Donoghue, Ashley, Mechanic, Oren, Dechen, Tenzin, Stevens, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425149/
https://www.ncbi.nlm.nih.gov/pubmed/36036937
http://dx.doi.org/10.1001/jamanetworkopen.2022.28997
_version_ 1784778385549950976
author Anderson, Timothy S.
O’Donoghue, Ashley
Mechanic, Oren
Dechen, Tenzin
Stevens, Jennifer
author_facet Anderson, Timothy S.
O’Donoghue, Ashley
Mechanic, Oren
Dechen, Tenzin
Stevens, Jennifer
author_sort Anderson, Timothy S.
collection PubMed
description This cross-sectional study uses time-series data to evaluate the administration of bamlanivimab-etesevimab and casirivimab-imdevimab monoclonal antibody treatments for SARS-CoV-2 infection after the US Food and Drug Administration deauthorized their use in early 2022.
format Online
Article
Text
id pubmed-9425149
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-94251492022-09-16 Administration of Anti–SARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization Anderson, Timothy S. O’Donoghue, Ashley Mechanic, Oren Dechen, Tenzin Stevens, Jennifer JAMA Netw Open Research Letter This cross-sectional study uses time-series data to evaluate the administration of bamlanivimab-etesevimab and casirivimab-imdevimab monoclonal antibody treatments for SARS-CoV-2 infection after the US Food and Drug Administration deauthorized their use in early 2022. American Medical Association 2022-08-29 /pmc/articles/PMC9425149/ /pubmed/36036937 http://dx.doi.org/10.1001/jamanetworkopen.2022.28997 Text en Copyright 2022 Anderson TS et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Anderson, Timothy S.
O’Donoghue, Ashley
Mechanic, Oren
Dechen, Tenzin
Stevens, Jennifer
Administration of Anti–SARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization
title Administration of Anti–SARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization
title_full Administration of Anti–SARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization
title_fullStr Administration of Anti–SARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization
title_full_unstemmed Administration of Anti–SARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization
title_short Administration of Anti–SARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization
title_sort administration of anti–sars-cov-2 monoclonal antibodies after us food and drug administration deauthorization
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425149/
https://www.ncbi.nlm.nih.gov/pubmed/36036937
http://dx.doi.org/10.1001/jamanetworkopen.2022.28997
work_keys_str_mv AT andersontimothys administrationofantisarscov2monoclonalantibodiesafterusfoodanddrugadministrationdeauthorization
AT odonoghueashley administrationofantisarscov2monoclonalantibodiesafterusfoodanddrugadministrationdeauthorization
AT mechanicoren administrationofantisarscov2monoclonalantibodiesafterusfoodanddrugadministrationdeauthorization
AT dechentenzin administrationofantisarscov2monoclonalantibodiesafterusfoodanddrugadministrationdeauthorization
AT stevensjennifer administrationofantisarscov2monoclonalantibodiesafterusfoodanddrugadministrationdeauthorization

Ejemplares similares